William M. Mitchell

6.1k total citations · 2 hit papers
131 papers, 4.1k citations indexed

About

William M. Mitchell is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, William M. Mitchell has authored 131 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 28 papers in Immunology and 22 papers in Epidemiology. Recurrent topics in William M. Mitchell's work include HIV Research and Treatment (19 papers), T-cell and Retrovirus Studies (11 papers) and Reproductive tract infections research (11 papers). William M. Mitchell is often cited by papers focused on HIV Research and Treatment (19 papers), T-cell and Retrovirus Studies (11 papers) and Reproductive tract infections research (11 papers). William M. Mitchell collaborates with scholars based in United States, Italy and Germany. William M. Mitchell's co-authors include William E. Robinson, David C. Montefiori, John M. Taylor, Stanley Cohen, Charles W. Stratton, William F. Harrington, Shirley S. Schuffman, Song‐Yi Yao, Subramaniam Sriram and David N. Orth and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

William M. Mitchell

130 papers receiving 3.7k citations

Hit Papers

Epidermal Growth Factor 1970 2026 1988 2007 1972 1970 50 100 150

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
William M. Mitchell 1.3k 870 709 631 469 131 4.1k
Ingrid Schmid 1.2k 0.9× 1.1k 1.3× 578 0.8× 336 0.5× 352 0.8× 63 3.2k
Jason B. Weinberg 1.4k 1.0× 1.7k 2.0× 304 0.4× 769 1.2× 544 1.2× 122 5.0k
Omar Bagasra 1.9k 1.4× 1.3k 1.5× 1.7k 2.4× 1.4k 2.2× 756 1.6× 163 7.0k
Joseph Bryant 1.3k 0.9× 565 0.6× 712 1.0× 684 1.1× 610 1.3× 139 4.2k
Antonella Caputo 2.4k 1.8× 1.2k 1.4× 1.4k 2.0× 685 1.1× 605 1.3× 127 4.7k
Alain Moreau 1.3k 0.9× 283 0.3× 438 0.6× 716 1.1× 248 0.5× 166 4.3k
Kazuo Takahashi 2.4k 1.8× 1.6k 1.8× 228 0.3× 1.7k 2.8× 538 1.1× 311 8.1k
Eiji Ishikawa 2.9k 2.1× 673 0.8× 341 0.5× 431 0.7× 250 0.5× 231 5.8k
Brigitte T. Huber 1.3k 1.0× 2.7k 3.1× 244 0.3× 640 1.0× 997 2.1× 146 5.5k
Michelangelo Foti 3.7k 2.7× 878 1.0× 670 0.9× 1.5k 2.3× 356 0.8× 109 7.1k

Countries citing papers authored by William M. Mitchell

Since Specialization
Citations

This map shows the geographic impact of William M. Mitchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William M. Mitchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William M. Mitchell more than expected).

Fields of papers citing papers by William M. Mitchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William M. Mitchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William M. Mitchell. The network helps show where William M. Mitchell may publish in the future.

Co-authorship network of co-authors of William M. Mitchell

This figure shows the co-authorship network connecting the top 25 collaborators of William M. Mitchell. A scholar is included among the top collaborators of William M. Mitchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William M. Mitchell. William M. Mitchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Corona, Angela, et al.. (2023). Ebola virus disease: In vivo protection provided by the PAMP restricted TLR3 agonist rintatolimod and its mechanism of action. Antiviral Research. 212. 105554–105554. 2 indexed citations
2.
Strayer, David R., Diane Young, & William M. Mitchell. (2020). Effect of disease duration in a randomized Phase III trial of rintatolimod, an immune modulator for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. PLoS ONE. 15(10). e0240403–e0240403. 19 indexed citations
3.
Weiss, Glen J., Julia Beck, Donald P. Braun, et al.. (2017). Tumor Cell–Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy. Clinical Cancer Research. 23(17). 5074–5081. 113 indexed citations
4.
Edmonds, Kyle P., et al.. (2014). Clinical Supervision in the Palliative Care Team Setting: A Concrete Approach to Team Wellness. Journal of Palliative Medicine. 18(3). 274–277. 22 indexed citations
6.
Strayer, David R., William A. Carter, Bruce C. Stouch, et al.. (2012). A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome. PLoS ONE. 7(3). e31334–e31334. 63 indexed citations
7.
Beck, Julia, Howard B. Urnovitz, William M. Mitchell, & Ekkehard Schütz. (2010). Next Generation Sequencing of Serum Circulating Nucleic Acids from Patients with Invasive Ductal Breast Cancer Reveals Differences to Healthy and Nonmalignant Controls. Molecular Cancer Research. 8(3). 335–342. 48 indexed citations
8.
Beck, Julia, Howard B. Urnovitz, Marina Saresella, et al.. (2010). Serum DNA Motifs Predict Disease and Clinical Status in Multiple Sclerosis. Journal of Molecular Diagnostics. 12(3). 312–319. 18 indexed citations
9.
Tang, Yi‐Wei, Subramaniam Sriram, Haijing Li, et al.. (2009). Qualitative and Quantitative Detection of Chlamydophila pneumoniae DNA in Cerebrospinal Fluid from Multiple Sclerosis Patients and Controls. PLoS ONE. 4(4). e5200–e5200. 12 indexed citations
10.
Ichinohe, Takeshi, Shinichi Tamura, Akira Kawaguchi, et al.. (2007). Cross‐Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine. The Journal of Infectious Diseases. 196(9). 1313–1320. 107 indexed citations
11.
King, Lloyd E., et al.. (2001). Diabetic Foot Ulcers and Chlamydia pneumoniae: Innocent Bystander or Opportunistic Pathogen?. Archives of Dermatology. 137(5). 671–671. 1 indexed citations
12.
Yao, Song‐Yi, et al.. (2001). Regulation by IFN-β of Inducible Nitric Oxide Synthase and Interleukin-12/p40 in Murine Macrophages Cultured in the Presence of Chlamydia pneumoniae Antigens. Journal of Interferon & Cytokine Research. 21(3). 137–146. 15 indexed citations
13.
Mitchell, William M., Lingmei Ding, & Jerome L. Gabriel. (1998). Inactivation of a common epitope responsible for the induction of antibody-dependent enhancement of HIV. AIDS. 12(2). 147–156. 13 indexed citations
14.
Mitchell, William M., S. Trent Rosenbloom, & Jerome L. Gabriel. (1995). Induction of mucosal anti-HIV antibodies by facilitated transfection of airway epithelium with lipospermine/DNA complexes. Immunotechnology. 1(3-4). 211–219. 7 indexed citations
15.
Montefiori, David C., William E. Robinson, & William M. Mitchell. (1989). Antibody-independent, complement-mediated enhancement of HIV-1 infection by mannosidase I and II inhibitors. Antiviral Research. 11(3). 137–146. 17 indexed citations
16.
Montefiori, David C., William E. Robinson, & William M. Mitchell. (1988). Mismatched dsRNA (Ampligen) induces protection against genomic variants of the human immunodeffciency virus type 1 (HIV-1) in a multiplicity of target cells. Antiviral Research. 9(1-2). 47–55. 9 indexed citations
17.
Robinson, William E., William M. Mitchell, William H. Chambers, et al.. (1988). Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. Human Pathology. 19(5). 535–540. 23 indexed citations
18.
Montefiori, David C. & William M. Mitchell. (1987). Persistent coinfection of T lymphocytes with HTLV-II and HIV and the role of syncytium formation in HIV-induced cytopathic effect. Virology. 160(2). 372–378. 21 indexed citations
19.
Mitchell, William M., et al.. (1983). SPONTANEOUS AND INTERFERON RESISTANT NATURAL KILLER CELL ANERGY IN AIDS. PubMed. 1(3). 221–229. 15 indexed citations
20.
Nishioka, Kenji, Andreas Constantopoulos, Paul S. Satoh, William M. Mitchell, & Victor A. Najjar. (1973). Characteristics and isolation of the phagocytosis-stimulating peptide, tuftsin. Biochimica et Biophysica Acta (BBA) - Protein Structure. 310(1). 217–229. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026